How much is Azalea Therapeutics worth in 2026?

Azalea Therapeutics has a current valuation of $153.0M based on their Early Stage VC round and secondary market data.

How much funding has Azalea Therapeutics raised?

Azalea Therapeutics has raised $82.0M in total funding across 1 funding rounds.

Azalea Therapeutics

BiotechnologyWebsite

Azalea Therapeutics valuation and funding history | Last updated: October 30, 2025 | 1 funding rounds

Current Valuation

$153.0M

As of October 30, 2025

Total Funding Raised

$82.0M

Across 1 round

Last Round

Early Stage VC

$65.0M

Last Funding

Oct 2025

Funding date

Capital Efficiency

1.87x

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
October 30, 2025	Early Stage VC (Series A)	$65.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Azalea Therapeutics is currently valued at $153.0M as of October 30, 2025. The company has raised a total of $82.0M in funding across 1 funding round.

Capital Efficiency

With a capital efficiency ratio of 1.87x, Azalea Therapeutics has achieved a valuation that is 1.87 times the total capital raised.

Track Azalea Therapeutics Valuation Updates

Get notified when Azalea Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Azalea Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Azalea Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Azalea Therapeutics Worth in 2026?

Azalea Therapeutics is a leading private company in the Biotechnology sector. Track Azalea Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Azalea Therapeutics Valuation is Determined

Private company valuations like Azalea Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.